NCT00158522View on ClinicalTrials.gov

Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Hepatitis C
Interventions
DRUG

pegylated interferon alpha2a

Trial Locations (1)

Unknown

National Hepatology and Tropical Medicine Research Institute, Cairo

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00158522 - Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213) | Biotech Hunter | Biotech Hunter